- Home
- NNBR vs WHWK Comparison
NNBR vs WHWK Comparison
Compare NNBR & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNBR
- WHWK
- Stock Information
- Founded
- NNBR 1980
- WHWK 2007
- Country
- NNBR United States
- WHWK United States
- Employees
- NNBR N/A
- WHWK N/A
- Industry
- NNBR Industrial Machinery/Components
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- NNBR Industrials
- WHWK Health Care
- Exchange
- NNBR Nasdaq
- WHWK Nasdaq
- Market Cap
- NNBR 111.0M
- WHWK 91.9M
- IPO Year
- NNBR 1994
- WHWK N/A
- Fundamental
- Price
- NNBR $2.11
- WHWK $1.92
- Analyst Decision
- NNBR
- WHWK
- Analyst Count
- NNBR 0
- WHWK 0
- Target Price
- NNBR N/A
- WHWK N/A
- AVG Volume (30 Days)
- NNBR 549.3K
- WHWK 144.3K
- Earning Date
- NNBR 08-06-2025
- WHWK 08-15-2025
- Dividend Yield
- NNBR N/A
- WHWK N/A
- EPS Growth
- NNBR N/A
- WHWK N/A
- EPS
- NNBR N/A
- WHWK 0.91
- Revenue
- NNBR $448,780,000.00
- WHWK $27,775,000.00
- Revenue This Year
- NNBR N/A
- WHWK $49.83
- Revenue Next Year
- NNBR $4.96
- WHWK N/A
- P/E Ratio
- NNBR N/A
- WHWK $2.10
- Revenue Growth
- NNBR N/A
- WHWK 16.51
- 52 Week Low
- NNBR $1.58
- WHWK $1.21
- 52 Week High
- NNBR $4.67
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- NNBR 46.59
- WHWK N/A
- Support Level
- NNBR $1.80
- WHWK N/A
- Resistance Level
- NNBR $2.14
- WHWK N/A
- Average True Range (ATR)
- NNBR 0.13
- WHWK 0.00
- MACD
- NNBR -0.01
- WHWK 0.00
- Stochastic Oscillator
- NNBR 36.59
- WHWK 0.00
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.